title: Report of the Second Equine Leucocyte Antigen Workshop, Squaw valley, California, July 1995.
abstract: The final assignment of antibody clusters for leucocyte antigens and immunoglobulins, as described in detail in Sections 3 and 4, is summarized in Table 4. Together with other mAbs developed outside of ELAW II (Table 9) this pool of reagents represent a powerful array of tools for the study of equine immunity. The Second Equine Leucocyte Antigen Workshop made considerable advances in pursuing the objectives of establishing the specificities of mAbs and achieving consensus on the nomenclature for equine leucocyte and immunoglobulin molecules. Of equal importance, several productive collaborations were fostered among the participating laboratories and observers. Overall, enormous advances have been made in the past decade since mAbs specific for equine leucocyte antigens and immunoglobulins were first reported. There remains enormous scope and need for further studies of equine leucocyte antigens and immunoglobulins, both for the purposes of comparative immunology and for the good of the horse. In the future novel techniques will be required to develop reagents for specific target antigens such as the orthologues of the CD25 or CD45 isoforms. In studies of equine immunoglobulins the functional role of the IgG isotypes must be better established, reagents for IgE must be developed, and cloning of the immunoglobulin heavy chain genes will be essential if the complexities of the IgG sub-isotypes are to be elucidated. The tasks still facing the currently small group of equine immunologists throughout the world remain formidable, and will only be tackled successfully in a spirit of collaboration.
authors.affiliation: School of Veterinary Medicine, University of Wisconsin, Madison 53706, USA. lunnp@svm.vetmed.wisc.edu
authors.forename: D P
authors.initials: DP
authors.lastname: Lunn
authors.forename: M A
authors.initials: MA
authors.lastname: Holmes
authors.forename: D F
authors.initials: DF
authors.lastname: Antczak
authors.forename: N
authors.initials: N
authors.lastname: Agerwal
authors.forename: J
authors.initials: J
authors.lastname: Baker
authors.forename: S
authors.initials: S
authors.lastname: Bendali-Ahcene
authors.forename: M
authors.initials: M
authors.lastname: Blanchard-Channell
authors.forename: K M
authors.initials: KM
authors.lastname: Byrne
authors.forename: K
authors.initials: K
authors.lastname: Cannizzo
authors.forename: W
authors.initials: W
authors.lastname: Davis
authors.forename: M J
authors.initials: MJ
authors.lastname: Hamilton
authors.forename: D
authors.initials: D
authors.lastname: Hannant
authors.forename: T
authors.initials: T
authors.lastname: Kondo
authors.forename: J H
authors.initials: JH
authors.lastname: Kydd
authors.forename: M C
authors.initials: MC
authors.lastname: Monier
authors.forename: P F
authors.initials: PF
authors.lastname: Moore
authors.forename: T
authors.initials: T
authors.lastname: O'Neil
authors.forename: B R
authors.initials: BR
authors.lastname: Schram
authors.forename: A
authors.initials: A
authors.lastname: Sheoran
authors.forename: J L
authors.initials: JL
authors.lastname: Stott
authors.forename: T
authors.initials: T
authors.lastname: Sugiura
authors.forename: K E
authors.initials: KE
authors.lastname: Vagnoni
mesh_terms: D000818:Animals; D006649:Histocompatibility Antigens / Q000145:classification / Q000276:immunology*; D006736:Horses / Q000276:immunology*; D007136:Immunoglobulins / Q000145:classification / Q000276:immunology; D007158:Immunologic Techniques
chemical_list: D006649:Histocompatibility Antigens; D007136:Immunoglobulins